Podcast
Heard at ISPOR: Debating the Benefits and Pitfalls of the QALY
During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year (QALY) from various perspectives. During this podcast, we sit down with 2 of the panelists to continue the QALY discussion.
During the ISPOR 2019 annual meeting, a panel discussion debated the good and the bad about the quality-adjusted life-year from various perspectives.
During this podcast, we sit down with Jennifer Bright, MPA, the executive director of the Innovation and Value Initiative, who moderated the discussion, and Lou Garrison, PhD, assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, who participated in the discussion.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
